{"entity":{"type":"insider","cik":"0001797467","url":"/insider/0001797467","json_url":"/insider/0001797467.json","name":"Francomano Robert","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2020-01-03","last":"2020-05-06","span_basis":"filed_date"},"name_variants":[{"name":"Francomano Robert","source":"filing","n_filings":4,"first_seen":"2020-01-03","last_seen":"2020-05-06"}],"transactions":[{"id":2921893,"accession":"0001104659-20-057631","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-057631","line_url":"/filing/0001104659-20-057631#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":272.0,"shares_display":"272","price_per_share":11.51,"price_display":"11.51","price_state":"stated","total_value":3130.72,"total_display":"3,130.72","total_whole":"3,131","shares_owned_after":197658.0,"shares_owned_after_display":"197,658","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-04","filed_date":"2020-05-06","scope":"insider"},{"id":2212739,"accession":"0001104659-20-033490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-033490","line_url":"/filing/0001104659-20-033490#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1266.0,"shares_display":"1,266","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":6330.0,"total_display":"6,330.00","total_whole":"6,330","shares_owned_after":197930.0,"shares_owned_after_display":"197,930","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-09","filed_date":"2020-03-13","scope":"insider"},{"id":2297393,"accession":"0001104659-20-022139","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-022139","line_url":"/filing/0001104659-20-022139#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5064.0,"shares_display":"5,064","price_per_share":6.72,"price_display":"6.72","price_state":"stated","total_value":34030.08,"total_display":"34,030.08","total_whole":"34,030","shares_owned_after":93257.0,"shares_owned_after_display":"93,257","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-07","filed_date":"2020-02-14","scope":"insider"},{"id":2689003,"accession":"0001104659-20-000976","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-000976","line_url":"/filing/0001104659-20-000976#line-4","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":116.0,"shares_display":"116","price_per_share":10.48,"price_display":"10.48","price_state":"stated","total_value":1215.68,"total_display":"1,215.68","total_whole":"1,216","shares_owned_after":98321.0,"shares_owned_after_display":"98,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-27","filed_date":"2020-01-03","scope":"insider"},{"id":2688998,"accession":"0001104659-20-000976","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-20-000976","line_url":"/filing/0001104659-20-000976#line-3","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":893.0,"shares_display":"893","price_per_share":10.75,"price_display":"10.75","price_state":"stated","total_value":9599.75,"total_display":"9,599.75","total_whole":"9,600","shares_owned_after":98437.0,"shares_owned_after_display":"98,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-26","filed_date":"2020-01-03","scope":"insider"},{"id":2688994,"accession":"0001104659-20-000976","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-000976","line_url":"/filing/0001104659-20-000976#line-2","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1412.0,"shares_display":"1,412","price_per_share":10.97,"price_display":"10.97","price_state":"stated","total_value":15489.64,"total_display":"15,489.64","total_whole":"15,490","shares_owned_after":99330.0,"shares_owned_after_display":"99,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-24","filed_date":"2020-01-03","scope":"insider"},{"id":2688987,"accession":"0001104659-20-000976","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-20-000976","line_url":"/filing/0001104659-20-000976#line-1","is_derivative":false,"issuer_cik":"0001264587","issuer_name":"STEMLINE THERAPEUTICS INC","issuer_ticker":"STML","issuer_name_source":null,"issuer_url":"/issuer/0001264587","owner_cik":"0001797467","owner_name":"Francomano Robert","owner_display_name":"Francomano Robert","owner_url":"/insider/0001797467","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":249.0,"shares_display":"249","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":2634.42,"total_display":"2,634.42","total_whole":"2,634","shares_owned_after":100742.0,"shares_owned_after_display":"100,742","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-23","filed_date":"2020-01-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001264587","name":"STEMLINE THERAPEUTICS INC","url":"/issuer/0001264587","role":"Officer (Chief Commercial Officer)","n_filings":4,"first_seen":"2020-01-03","last_seen":"2020-05-06"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001797467","retrieved_at":"2026-08-27T05:47:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}